Topic:

Chutes and Ladders

Latest Headlines

Latest Headlines

PatientsLikeMe nabs Merck informatics veteran to lead R&D

PatientsLikeMe has lured Jason Johnson away from Merck. Johnson is leaving Merck after 14 years at the Big Pharma to head up R&D at PatientsLikeMe, a role which gives him responsibility for efforts to extract insights from patient-reported data.

Heading for startup Denali, Tessier-Lavigne to leave Pfizer board

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or...

UPDATED: Pfizer gets friendly backing in appeal over blind rep's bid for paid driver

In the department of employee lawsuits, Pfizer is the latest drugmaker in the hot seat. But the seat is hotter for the visually impaired sales rep who sued because the company wouldn't provide a driver to ferry her to doctors' offices.

Nima Farzan takes over as PaxVax CEO

Nima Farzan, who previously served as chief operating officer, will take the helm as CEO of PaxVax, the company announced Monday. Ken Kelley, co-founder and former CEO, will remain on the board of directors and will serve as an advanced leadership initiative fellow at Harvard University.

BMS looks to Caforio as next CEO

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or...

Lundbeck bags Novo exec Schultz to engineer a much-needed turnaround

Mystery solved: Novo Nordisk heir apparent Kåre Schultz didn't just up and leave the Danish drugmaker. He left for the top job at crosstown colleague Lundbeck, vacant since that CEO stepped down in disgrace in November.

Caforio takes CEO role as BMS faces tough year with promising new drugs

Trained in his native Italy as a doctor, Giovanni Caforio speaks not only English and Italian, but also Spanish, French and Portuguese. As he steps into the CEO role today at Bristol-Myers Squibb, the question will be how well he speaks dollars and cents.

Canon appoints Tanaka as CEO, president of U.S. subsidiary

Canon's American unit, Canon U.S.A., said it has appointed Akiko Tanaka to be both CEO and president of its wholly owned subsidiary, Canon U.S. Life Sciences.

COO Schultz out of a job after Novo's executive shuffle

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or...

Ex-Sanofi exec Whitaker lands at Valeant in EVP role

After departing from Sanofi last year for the CEO's chair at Synta Pharmaceuticals, Anne Whitaker is now moving on to Valeant, where she'll step into the role of EVP and group chairman.